Aurobindo, Torrent Infringe Sanofi's Uroxatral IP: Judge
A federal judge has ruled that Sanofi-Aventis' patent covering prostate treatment Uroxatral is valid and infringed by proposed generic versions from Aurobindo Pharma Ltd. and Torrent Pharma Inc....To view the full article, register now.
Already a subscriber? Click here to view full article